WELLINGTON MANAGEMENT GROUP LLP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$497,000
+10.4%
88,7410.0%0.00%
Q2 2018$450,000
-25.6%
88,7410.0%0.00%
Q1 2018$605,000
+3.2%
88,741
+14.2%
0.00%
Q4 2017$586,000
+31.1%
77,6880.0%0.00%
Q3 2017$447,00077,6880.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 778,230$5,308,0005.22%
BVF INC/IL 3,592,549$24,501,0002.48%
Prosight Management, LP 563,763$3,845,0002.41%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,456,0000.83%
Virtus ETF Advisers LLC 125,695$857,0000.74%
EAM Investors, LLC 521,460$3,556,0000.59%
Tekla Capital Management LLC 2,087,380$14,236,0000.55%
Orbimed Advisors 5,550,000$37,851,0000.47%
EAM Global Investors LLC 125,635$857,0000.44%
Schonfeld Strategic Advisors LLC 830,637$5,665,0000.42%
View complete list of PIERIS PHARMACEUTICALS INC shareholders